HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
132.55%
Total 13F principal
$359,958,200
Principal change
-$27,034,000
Total reported market value
$476,893,298
Number of holders
33
Value change
-$30,425,539
Number of buys
10
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q4 2019

As of 31 Dec 2019, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 33 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $359,958,200 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Allianz Asset Management GmbH, M&G INVESTMENT MANAGEMENT LTD, LAZARD ASSET MANAGEMENT LLC, STATE STREET CORP, WELLS FARGO & COMPANY/MN, SYMPHONY ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, Invesco Ltd., and CSS LLC/IL. This page lists 33 institutional bondholders reporting positions for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.